BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38408140)

  • 1. Effective Treatment of Anlotinib Combined With Chemotherapy in Children With Desmoplastic Small Round Cell Tumor: A Case Series in a Single-center and Literature Review.
    Jing XY; Shen CQ; He GQ; Xu RR; Gao J; Guo X
    J Pediatr Hematol Oncol; 2024 Apr; 46(3):159-164. PubMed ID: 38408140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of anlotinib in intra-abdominal desmoplastic small round cell tumors: a case report and literature review.
    Chen HM; Feng G
    Onco Targets Ther; 2019; 12():57-61. PubMed ID: 30588030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to chemotherapy combined with anlotinib plus anlotinib maintenance in intra-abdominal desmoplastic small round cell tumors (IADSRCT): a case report and literature review.
    Cheng K; Liu X; Chen Y; Zhou K; Li Z
    BMC Gastroenterol; 2022 Aug; 22(1):388. PubMed ID: 35978277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective treatment of apatinib in desmoplastic small round cell tumor: a case report and literature review.
    Shi C; Feng Y; Zhang LC; Ding DY; Yan MY; Pan L
    BMC Cancer; 2018 Mar; 18(1):338. PubMed ID: 29587657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor.
    Menegaz BA; Cuglievan B; Benson J; Camacho P; Lamhamedi-Cherradi SE; Leung CH; Warneke CL; Huh W; Subbiah V; Benjamin RS; Patel S; Daw N; Hayes-Jordan A; Ludwig JA
    Oncologist; 2018 Mar; 23(3):360-366. PubMed ID: 29212731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmoplastic Small Round Cell Tumor Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Results of a Phase 2 Trial.
    Hayes-Jordan AA; Coakley BA; Green HL; Xiao L; Fournier KF; Herzog CE; Ludwig JA; McAleer MF; Anderson PM; Huh WW
    Ann Surg Oncol; 2018 Apr; 25(4):872-877. PubMed ID: 29383611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switch maintenance therapy with anlotinib after chemotherapy in unresectable or metastatic soft tissue sarcoma: a single-center retrospective study.
    Liu J; Deng YT; Jiang Y
    Invest New Drugs; 2021 Apr; 39(2):330-336. PubMed ID: 32974853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy and Radioimmunotherapy for Desmoplastic Small Round Cell Tumor.
    Espinosa-Cotton M; Cheung NV
    Front Oncol; 2021; 11():772862. PubMed ID: 34869013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303.
    Si X; Zhang L; Wang H; Zhang X; Wang M; Han B; Li K; Wang Q; Shi J; Wang Z; Cheng Y; Shi Y; Chen W; Wang X; Luo Y; Nan K; Jin F
    Thorac Cancer; 2019 Mar; 10(3):551-556. PubMed ID: 30666799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anlotinib Combined with S-1 in the Third-Line Treatment of Stage IV Non-Small Cell Lung Cancer: Study Protocol for Phase II Clinical Trial.
    Yang X; Xiang M; Geng L; Wen Y; Du X
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3849-3853. PubMed ID: 31870132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete cytoreduction and HIPEC improves survival in desmoplastic small round cell tumor.
    Hayes-Jordan A; Green HL; Lin H; Owusu-Agyemang P; Fitzgerald N; Arunkumar R; Mejia R; Okhuysen-Cawley R; Mauricio R; Fournier K; Ludwig J; Anderson P
    Ann Surg Oncol; 2014 Jan; 21(1):220-4. PubMed ID: 24046124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmoplastic Small Round Cell Tumor: Long-Term Complications After Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy.
    Stiles ZE; Murphy AJ; Anghelescu DL; Brown CL; Davidoff AM; Dickson PV; Glazer ES; Bishop MW; Furman WL; Pappo AS; Lucas JT; Deneve JL
    Ann Surg Oncol; 2020 Jan; 27(1):171-178. PubMed ID: 30963398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Retrospective Cohort Study Evaluates Clinical Value of Anlotinib in Persistent, Metastatic, or Recurrent Cervical Cancer After Failure of First-Line Therapy.
    Yang H; Sun S; Mei Z; Xiang Q; Yang C; Chen M; Xie C; Zhou Y; Qiu H
    Drug Des Devel Ther; 2021; 15():4665-4674. PubMed ID: 34815663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy with anlotinib for patient with recurrent glioblastoma: A case report and literature review.
    Lv Y; Zhang J; Liu F; Song M; Hou Y; Liang N
    Medicine (Baltimore); 2019 May; 98(22):e15749. PubMed ID: 31145289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP-RT) experience.
    Desai NB; Stein NF; LaQuaglia MP; Alektiar KM; Kushner BH; Modak S; Magnan HM; Goodman K; Wolden SL
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e67-72. PubMed ID: 23084475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anlotinib is effective in the treatment of advanced pancreatic cancer: a case report.
    Li S; Niu M; Deng W; Li N; Wei C; Luo S
    Anticancer Drugs; 2022 Jan; 33(1):e558-e561. PubMed ID: 34387586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to first-line treatment predicts progression-free survival benefit of small-cell lung cancer patients treated with anlotinib.
    Qin B; Xin L; Hou Q; Yang B; Zhang J; Qi X; Wei Y; Hu Y; Xiong Q
    Cancer Med; 2021 Jun; 10(12):3896-3904. PubMed ID: 33960145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EWSR1::WT1 Fusions in Neoplasms Other Than Conventional Desmoplastic Small Round Cell Tumor: Three Tumors Occurring Outside the Female Genital Tract.
    Warmke LM; Perret R; Ledoux P; Michot A; Italiano A; Zou YS; Matoso A; Argani P; Ulbright TM; Baumhoer D; Ameline B; Gross JM
    Mod Pathol; 2024 Mar; 37(3):100418. PubMed ID: 38158126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we cure patients with abdominal Desmoplastic Small Round Cell Tumor? Results of a retrospective multicentric study on 100 patients.
    Honoré C; Delhorme JB; Nassif E; Faron M; Ferron G; Bompas E; Glehen O; Italiano A; Bertucci F; Orbach D; Pocard M; Quenet F; Blay JY; Carrere S; Chevreau C; Mir O; Le Cesne A;
    Surg Oncol; 2019 Jun; 29():107-112. PubMed ID: 31196472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel multi-target tyrosine kinase inhibitor anlotinib combined with irinotecan has in-vitro anti-tumor activity against human small-cell lung cancer.
    Li H; Liu Y; Liu X; Zhao D; Liu J; Cheng Y
    Anticancer Drugs; 2020 Nov; 31(10):1057-1064. PubMed ID: 32694423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.